Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Mild to Moderate Gait Impairment: A Feasibility Study [NA]
This clinical trial update describes a feasibility study aimed at improving motor skills in people with multiple sclerosis who have mild to …
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis [Phase 1]
An update on a Phase 1 study evaluating subcutaneous ocrelizumab in people with multiple sclerosis, focusing on pharmacokinetics, safety, an…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Effects of a Circuit Training on Balance in Persons With Multiple Sclerosis [NA]
This completed clinical trial evaluated the effects of circuit training on balance in persons with Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Effect of High Intensity Training on Motor and Cognitive Functions [NA]
This clinical trial is investigating the impact of high-intensity training on motor and cognitive functions in individuals with multiple scl…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple Sclerosis [NA]
This update reports completion of a clinical trial and posted results evaluating neural mechanisms of split-belt treadmill adaptation in peo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Telerehabilitation of Multidomain Cognitive Impairment in Multiple Sclerosis [NA]
A clinical trial evaluating telerehabilitation for multidomain cognitive impairment in multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: 3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME) [NA]
This clinical trial update describes a study evaluating 3D optimized WMN MPRAGE imaging (WHINUME) to improve detection of focal spinal cord …
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial (TOTEM) is evaluating testosterone treatment for neuroprotection and myelin repair in relapsing-remitting multiple …
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Exergaming With Immersive Virtual Reality For People With Multiple Sclerosis (ExeRVIEM) [NA]
A completed clinical trial (ExeRVIEM) evaluating immersive virtual reality exergaming as a rehabilitation approach for people with Multiple …
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: A Post-Authorization, Long-term Study of Ozanimod Real-world Safety
Post-authorization, long-term real-world safety study of Ozanimod for relapsing-remitting multiple sclerosis. The study is currently active …
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Exopulse Mollii Suit, Spasticity & Tissue Oxygenation [NA]
This clinical trial update indicates that the study evaluating the Exopulse Mollii Suit for spasticity and tissue oxygenation in Multiple Sc…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS) [Phase 3]
A Phase 3 randomized trial compares autologous hematopoietic stem cell transplantation to alemtuzumab, cladribine, or ocrelizumab for relaps…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A Teleheath tDCS Approach to Decrease Cannabis Use [Phase 2]
Phase 2 trial results for a telehealth transcranial direct current stimulation (tDCS) approach to reduce cannabis use in individuals with Ca…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)
Clinical trial update reporting results from the CLAD CROSS prospective effectiveness and safety study evaluating cladribine in people with …
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: A Specialized Diet for Multiple Sclerosis [NA]
A clinical trial is investigating a specialized diet for people with multiple sclerosis and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: The Effect of a Series of Systemic Cryotherapy Treatments on the Functional State of Patients With Multiple Sclerosis [NA]
A completed clinical trial evaluating the impact of systemic cryotherapy treatments on the functional state of patients with Multiple Sclero…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration [Phase 2]
This is a Phase 2 add-on trial evaluating metformin for brain remyelination and neurodegeneration in multiple sclerosis, including primary p…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Measurement of Relaxin Peptide in Multiple Sclerosis (MS)
A clinical trial evaluating the measurement of relaxin peptide in relapsing-remitting multiple sclerosis has completed enrollment and posted…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Screening for Cognitive Disorders in Multiple Sclerosis
This clinical trial update describes a study focused on screening for cognitive disorders in individuals with multiple sclerosis. The trial …
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Effectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple Sclerosis [NA]
This clinical trial update assesses the effectiveness of a one-year group fatigue-management program for individuals with minimally impaired…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Effects of Transcranial Electrical Stimulation on Cognitive Impairment in CNS Inflammatory Demyelinating Diseases [NA]
A clinical trial is evaluating whether transcranial electrical stimulation can improve cognitive impairment in CNS inflammatory demyelinatin…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Remote MS Care in Antwerp [NA]
A trial in Antwerp is evaluating remote care for people with multiple sclerosis and is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis [NA]
The clinical trial update notes that the EXOPULSE Mollii Suit trial for motor function in Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE [NA]
The PREMiSE trial, a prospective randomized study of endovascular therapy for multiple sclerosis, has completed and posted results on 2025-0…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
A clinical trial led by Icahn School of Medicine at Mount Sinai investigates longitudinal cortical demyelination in Multiple Sclerosis and r…